Flindr Therapeutics
PrivateLast Round
Series A
Apr 24, 2024
Total Funding Raised
$21.4M
Momentum Score
75 /100
Company Overview
Flindr Therapeutics is a biotechnology company developing a pipeline of first-in-class small molecule inhibitors for the precision treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flindr Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Flindr Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 24, 2024 |
Key People
Founding team and executive leadership
Flindr Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Seed, Series A |
| Swanbridge Capital | Seed, Series A |
| Qbic Fund | Series A |
| Innovatiefonds Noord-Holland | Seed |
| V-Bio Ventures | Series A |
| Flanders Future Tech Fund | Series A |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 24, 2026
Monthly visitors increased 505% MoM, from 74 to 448.
- May 12, 2025
Grew 40% QoQ from 10 to 14 employees.
Flindr Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Flindr Therapeutics's valuation, stock price, and market status.
